Rare diseases
Investigational molecules
Locations
Back to Italy2 684 clinical trials in Novara, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of depemokimab to improve airway function in patients with type 2 eosinophilic asthma
ItalyStudy of XELOX chemotherapy with or without dostarlimab after chemoradiation in patients with locally advanced rectal cancer
ItalyStudy of IMVT-1402 in Adults with Mild to Severe Generalized Myasthenia Gravis
ItalyStudy of toripalimab, cisplatin and gemcitabine combination as first treatment for patients with recurrent or metastatic nasopharyngeal cancer
ItalyStudy of oral rilzabrutinib for adults with immune thrombocytopenia who did not respond to first-line treatment
ItalyComparing brincidofovir and cidofovir for treating adenovirus infection in children and adults after stem cell transplantation
ItalyStudy of PRAX-628 to evaluate safety and effectiveness in adults with epilepsy who have focal seizures or generalized tonic-clonic seizures
ItalyStudy comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer
ItalyStudy of trastuzumab deruxtecan with pembrolizumab versus platinum chemotherapy with pembrolizumab for patients with untreated HER2-positive non-small cell lung cancer
ItalyStudy of nirogacestat in adult premenopausal women with desmoid tumors and aggressive fibromatosis to evaluate ovarian function recovery
ItalyStudy of ONL1204 eye injections to slow vision loss in patients with age-related macular degeneration and geographic atrophy
ItalyStudy comparing standard and reduced intensity treatment in patients with acute myeloid leukemia or chronic lymphocytic leukemia who have no detectable disease after initial therapy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on hematologic malignancies and solid tumors, investigating innovative treatments for various cancer types including leukemia, breast cancer, and lung cancer.
Studies evaluating combination therapies and targeted treatments to improve patient outcomes.
Research focusing on heart failure prevention and treatment strategies, particularly exploring new drug combinations and their impact on cardiovascular outcomes.
Innovative approaches combining multiple therapeutic agents to address cardiovascular risks.
Investigations into treatments for various autoimmune disorders, including Sjögren's Syndrome and rheumatoid arthritis, with emphasis on novel therapeutic approaches.
Focus on developing targeted therapies for better disease management and patient care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
